The Value of m5C-Related lncRNAs in the Prognostic Assessment and Immunotherapy of Stomach Adenocarcinoma.

He C, Zhu X, Kong F, Zhang X, Chai X, Zou C, Zhao D

Open source

DOI
10.1155/2022/2747799
Published
2022
Container
BioMed research international
Publisher
Not recorded
Open access
yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1155/2022/2747799,
  title = {The Value of m5C-Related lncRNAs in the Prognostic Assessment and Immunotherapy of Stomach Adenocarcinoma.},
  author = {He C and Zhu X and Kong F and Zhang X and Chai X and Zou C and Zhao D},
  year = {2022},
  journal = {BioMed research international},
  doi = {10.1155/2022/2747799},
  url = {https://doi.org/10.1155/2022/2747799}
}

RIS

TY  - JOUR
TI  - The Value of m5C-Related lncRNAs in the Prognostic Assessment and Immunotherapy of Stomach Adenocarcinoma.
AU  - He C
AU  - Zhu X
AU  - Kong F
AU  - Zhang X
AU  - Chai X
AU  - Zou C
AU  - Zhao D
PY  - 2022
JO  - BioMed research international
DO  - 10.1155/2022/2747799
UR  - https://doi.org/10.1155/2022/2747799
ER  - 

APA

C, H., X, Z., F, K., X, Z., X, C., C, Z., & D, Z. (2022). The Value of m5C-Related lncRNAs in the Prognostic Assessment and Immunotherapy of Stomach Adenocarcinoma.. BioMed research international. https://doi.org/10.1155/2022/2747799

Source records